FILTER
FILTERED INTERVIEW RESULTS
N. R. Munjal
VICE CHAIRMAN AND MANAGING DIRECTOR, IND-SWIFT LABORATORIES LTD & VICE-CHAIRMAN, IND-SWIFT LTD
Ind-Swift is a pharmaceutical manufacturing and marketing company based in Chandigarh with its strength in innovative pharmaceutical products.
GV Sanjay Reddy
VICE CHAIRMAN, GVK
GVK is a leader in infrastructure development and recently constructed Mumbai’s much acclaimed new airport.
Daara B. Patel
SECRETARY GENERAL, INDIAN DRUG MANUFACTURERS’ ASSOCIATION
The Indian Drug Manufacturers’ Association (IDMA) has over 1000 members comprising large, medium and small national manufacturers across the country.
Thomas Wicks
CHIEF STRATEGY OFFICER, TRIALSCOPE
TrialScope helps trial sponsors to comply with disclosure regulations and internal transparency policies for jurisdictions across the world and is developing a program to provide easily intelligible interpretations of trial results for the patients that are involved in trials.
Valarie Higgins
PRESIDENT & MANAGING DIRECTOR, ALMAC CLINICAL TECHNOLOGIES
Almac Clinical Technologies designs and deploys complex software that helps trial sponsors automate complex decisions that occur in clinical trials.
Josh Grauso
SALES MANAGER, UL CONSUMER & RETAIL SERVICES
UL helps companies meet safety and compliance standards and regulations across the pharma industry.
Christian Kopfli
CEO, CHROMOCELL
Chromocell is using its own Chrmovert technology to provide alternative pain blockers to opioids.
Renold Capocasale
CEO, FLOWMETRIC INC.
FlowMetric offers scientific analysis using Flow Cytometry to advance drug development.
Dirk van Peteghem
UPS VICE PRESIDENT, GLOBAL HEALTHCARE STRATEGY
UPS recently improved its offering to the pharmaceutical industry with the acquisition of Marken.
Scott Cubbler
COO LIFE SCIENCES & HEALTHCARE, GLOBAL, DHL SUPPLY CHAIN
DHL Supply Chain explains how the company keeps pace with changes such as recent demand for more biosimilars and personalized drugs.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
